Table 5.
Total, N = 240 | Males N = 165 | Females N = 74 | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Beta | SE | P-value | 95%CI | Beta | SE | P-value | 95%CI | Beta | SE | P-value | 95%CI | |
Age | − 0.024 | 0.096 | 0.804 | −0.213-0.165 | − 0.062 | 0.116 | 0.595 | − 0.291-0.167 | 0.016 | 0.182 | 0.929 | −0.347-0.380 |
BMI | −0.063 | 0.171 | 0.714 | −0.401-0.275 | − 0.307 | 0.246 | 0.214 | −0.793-0.179 | 0.178 | 0.235 | 0.451 | −0.291-0.648 |
Gender | −0.765 | 1.53 | 0.618 | −3.779-2.250 | – | – | – | – | – | – | – | – |
FVC % predicted | 0.225 | 0.084 | 0.008* | 0.060–0.389 | 0.246 | 0.107 | 0.023* | 0.034–0.458 | 0.191 | 0.138 | 0.169 | −0.083-0.466 |
FEV1% predicted | −0.03 | 0.078 | 0.699 | −0.184-0.124 | −0.047 | 0.095 | 0.618 | −0.234-0.140 | −0.02 | 0.143 | 0.889 | −0.305-0.265 |
Comorbidities status | −0.7 | 0.546 | 0.201 | −1.775-0.375 | −0.865 | 0.647 | 0.183 | −2.144-0.413 | 0.06 | 1.052 | 0.955 | −2.038-2.158 |
BMI Body Mass Index, FVC% forced vital capacity, % of expected, FEV1% forced expiratory volume in first second, % of expected
*p < 0.05